Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology leverages molecular simulations to examine a vast array of proteins, capturing their dynamics in both isolated forms and in complexes with other proteins. Through ensemble virtual screening, we thoroughly account for the protein's conformational mobility, identifying critical binding sites within functional regions and distant allosteric locations. This detailed exploration ensures that we comprehensively assess every possible mechanism of action, with the objective of identifying novel therapeutic targets and lead compounds that span a wide spectrum of biological functions.
Our library stands out due to several important features:
partner
Reaxense
upacc
A8MTJ3
UPID:
GNAT3_HUMAN
Alternative names:
Gustducin alpha-3 chain
Alternative UPACC:
A8MTJ3; A4D1B2; A4D1B3; B9EJG5
Background:
The Guanine nucleotide-binding protein G(t) subunit alpha-3, also known as Gustducin alpha-3 chain, plays a crucial role in taste perception, including bitter, sweet, and umami tastes. It functions by coupling taste receptor cells to specific signaling pathways, involving cGMP-phosphodiesterase activation, which leads to neurotransmitter release. This protein also acts as a sugar sensor in the gut, influencing the expression of Na+-glucose transporter and the secretion of metabolic hormones.
Therapeutic significance:
Understanding the role of Guanine nucleotide-binding protein G(t) subunit alpha-3 could open doors to potential therapeutic strategies.